| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | P M Tulkens | |
| M P Mingeot-Leclercq | |||
| Y Glupczynski | |||
| P2860 | cites work | Biologically important conformations of aminoglycoside antibiotics bound to an aminoglycoside 3'-phosphotransferase as determined by transferred nuclear Overhauser effect spectroscopy | Q73119728 |
| Design and analysis of molecular motifs for specific recognition of RNA | Q73509310 | ||
| RNA as a drug target | Q73513385 | ||
| Synthesis of 3'-deoxykanamycin effective against kanamycin-resistant Escherichia coli and Pseudomonas aeruginosa | Q93822602 | ||
| Multidrug efflux pumps of gram-negative bacteria | Q24681708 | ||
| Structural investigation of the antibiotic and ATP-binding sites in kanamycin nucleotidyltransferase | Q27729704 | ||
| Molecular structure of kanamycin nucleotidyltransferase determined to 3.0-A resolution | Q27731439 | ||
| Structure of the A site of Escherichia coli 16S ribosomal RNA complexed with an aminoglycoside antibiotic | Q27733872 | ||
| Structure of an enzyme required for aminoglycoside antibiotic resistance reveals homology to eukaryotic protein kinases | Q28242098 | ||
| Broad spectrum aminoglycoside phosphotransferase type III from Enterococcus: overexpression, purification, and substrate specificity | Q28254805 | ||
| Kinetic mechanism of aminoglycoside phosphotransferase type IIIa. Evidence for a Theorell-Chance mechanism | Q28289501 | ||
| Purification and characterization of aminoglycoside 3'-phosphotransferase type IIa and kinetic comparison with a new mutant enzyme | Q33752107 | ||
| Antimicrobial activity of arbekacin, a new aminoglycoside antibiotic, against methicillin-resistant Staphylococcus aureus | Q34311237 | ||
| Antibiotic G-418, a New Micromonospora-Produced Aminoglycoside with Activity Against Protozoa and Helminths: Antiparasitic Activity | Q34517755 | ||
| Structure-activity relationships among the aminoglycoside antibiotics: role of hydroxyl and amino groups | Q34661679 | ||
| G-418, an elongation inhibitor of 80 S ribosomes | Q34707729 | ||
| A new selective agent for eukaryotic cloning vectors | Q34714375 | ||
| Recognition of aminoglycoside antibiotics by enterococcal-staphylococcal aminoglycoside 3'-phosphotransferase type IIIa: role of substrate amino groups | Q35129429 | ||
| Adaptive resistance of Pseudomonas aeruginosa induced by aminoglycosides and killing kinetics in a rabbit endocarditis model | Q35135145 | ||
| Overexpression and characterization of the chromosomal aminoglycoside 6'-N-acetyltransferase from Enterococcus faecium | Q35135819 | ||
| An extracellular factor regulating expression of the chromosomal aminoglycoside 2'-N-acetyltransferase of Providencia stuartii | Q35137673 | ||
| Cloning and characterization of an aminoglycoside 6'-N-acetyltransferase gene from Citrobacter freundii which confers an altered resistance profile | Q35138904 | ||
| Agents that increase the permeability of the outer membrane. | Q35403079 | ||
| Mechanisms of action of aminoglycoside antibiotics in eucaryotic protein synthesis | Q35639534 | ||
| Comparison of aminoglycoside resistance patterns in Japan, Formosa, and Korea, Chile, and the United States | Q35646300 | ||
| Purification and characterization of aminoglycoside-modifying enzymes from Staphylococcus aureus and Staphylococcus epidermidis | Q35760739 | ||
| First-exposure adaptive resistance to aminoglycoside antibiotics in vivo with meaning for optimal clinical use. | Q36752618 | ||
| Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. | Q37058913 | ||
| New aspects of antimicrobial resistance and the resulting therapeutic dilemmas | Q37727456 | ||
| Genetic analysis of bacterial acetyltransferases: identification of amino acids determining the specificities of the aminoglycoside 6'-N-acetyltransferase Ib and IIa proteins | Q38328977 | ||
| The changing nature of aminoglycoside resistance mechanisms and the role of isepamicin--a new broad-spectrum aminoglycoside. The Aminoglycoside Resistance Study Groups. | Q38563911 | ||
| Aminoglycoside-induced hearing loss in humans | Q38676819 | ||
| The uptake and intracellular accumulation of aminoglycoside antibiotics in lysosomes of cultured rat fibroblasts | Q39184496 | ||
| Stability of dactimicin to aminoglycoside-modifying enzymes produced by 341 bacterial clinical isolates | Q39486219 | ||
| An antibiotic-binding motif of an RNA fragment derived from the A-site-related region of Escherichia coli 16S rRNA. | Q39717482 | ||
| Aminoglycoside research 1975-1985: prospects for development of improved agents | Q39733244 | ||
| Influence of pH on adaptive resistance of Pseudomonas aeruginosa to aminoglycosides and their postantibiotic effects. | Q39781139 | ||
| Active efflux of antimicrobial agents in wild-type strains of enterococci. | Q39784018 | ||
| MdfA, an Escherichia coli multidrug resistance protein with an extraordinarily broad spectrum of drug recognition | Q39845128 | ||
| Overproduction of 3'-aminoglycoside phosphotransferase type I confers resistance to tobramycin in Escherichia coli | Q39864810 | ||
| Single-base mutations at position 2661 of Escherichia coli 23S rRNA increase efficiency of translational proofreading | Q39940128 | ||
| Interaction of aminoglycosides with the outer membranes and purified lipopolysaccharide and OmpF porin of Escherichia coli | Q40086724 | ||
| Aminoglycoside uptake and mode of action--with special reference to streptomycin and gentamicin. I. Antagonists and mutants | Q40262525 | ||
| Pharmacokinetic contributions to postantibiotic effects. Focus on aminoglycosides | Q40589859 | ||
| Post-antibiotic effects in experimental infection models: relationship to in-vitro phenomena and to treatment of infections in man. | Q40827402 | ||
| Inhibition of aminoglycoside antibiotic resistance enzymes by protein kinase inhibitors | Q40881651 | ||
| The bactericidal action of streptomycin: membrane permeabilization caused by the insertion of mistranslated proteins into the cytoplasmic membrane of Escherichia coli and subsequent caging of the antibiotic inside the cells due to degradation of the | Q41092604 | ||
| Cellular toxicity of aminoglycoside antibiotics in G418-sensitive and -resistant LLC-PK1 cells | Q41470637 | ||
| Bacterial resistance to aminoglycoside antibiotics | Q41522159 | ||
| Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production | Q41526627 | ||
| Roles of ribosomal binding, membrane potential, and electron transport in bacterial uptake of streptomycin and gentamicin | Q42095864 | ||
| Mechanism of action of habekacin, a novel amino acid-containing aminoglycoside antibiotic | Q42115532 | ||
| Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide-dependent protein kinase and protein kinase C | Q42244464 | ||
| Urinary isolates of apramycin-resistant Escherichia coli and Klebsiella pneumoniae from Dublin | Q42758422 | ||
| Detection of apramycin resistant Enterobacteriaceae in hospital isolates | Q43893913 | ||
| Epidemiological studies of aminoglycoside resistance in the U.S.A | Q44200596 | ||
| The syntheses and biological properties of 1-N-(S-4-amino-2-hydroxybutyryl)-gentamicin B and 1-N-(S-3-amino-2-hydroxypropionyl)-gentamicin B. | Q44236334 | ||
| Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration | Q44483617 | ||
| Structure-based discovery of ligands targeted to the RNA double helix. | Q45970220 | ||
| The most frequent aminoglycoside resistance mechanisms--changes with time and geographic area: a reflection of aminoglycoside usage patterns? Aminoglycoside Resistance Study Groups | Q50136396 | ||
| Synthesis of 2"-oxidized derivatives of 5-deoxy-5-epi-5-fluoro-dibekacin and -arbekacin, and study on structure-chemical shift relationships of urethane(or amide)-type NH protons in synthetic intermediates. | Q51546183 | ||
| Alternative substrate and inhibition kinetics of aminoglycoside nucleotidyltransferase 2''-I in support of a Theorell-Chance kinetic mechanism. | Q52564749 | ||
| BB-K 8, a new semisynthetic aminoglycoside antibiotic | Q53854812 | ||
| Antibacterial activity and ototoxicity in guinea pigs, and nephrotoxicity in rats of arbekacin. | Q53885852 | ||
| A new antibiotic XK-62-2 (Sagamicin). I. Isolation, physicochemical and antibacterial properties. | Q53942670 | ||
| Synthesis of dibekacin analogs containing 3-oxa- and 3-aza-2,3,4-trideoxy-D-glycero-hexopyranose. | Q53980687 | ||
| A synthetic study of methyl 3-deoxy-3-fluoro-alpha-D-glucopyranosides from methyl 2,3-anhydro-alpha-D-allopyranosides, and synthesis of 3'-deoxy-3'-fluorokanamycin A and 3'-chloro-3'-deoxykanamycin A | Q54067249 | ||
| Purification, characterization, and investigation of the mechanism of aminoglycoside 3'-phosphotransferase type Ia. | Q54160121 | ||
| Active-site labeling of an aminoglycoside antibiotic phosphotransferase (APH(3')-IIIa). | Q54190990 | ||
| Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents. IV. Aminoglycoside-modifying enzyme AAC(6')/APH(2") is responsible for arbekacin-resistance enhanced by bleomycin. | Q54196937 | ||
| Structures of enzymatically modified products of arbekacin by methicillin-resistant. Staphylococcus aureus. | Q54247959 | ||
| New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation. | Q54298674 | ||
| Synthesis of 3'-deoxy-3'-fluorokanamycin A and 3',4'-dideoxy-3'-fluorokanamycin A. | Q54299872 | ||
| Resistance to aminoglycoside antibiotics in gram-negative bacilli and staphylococci isolated from blood. Report from a European collaborative study. The ESGAR Study Group (European Study Group on Antibiotic Resistance). | Q54320617 | ||
| Substrate specificities and structure-activity relationships for the nucleotidylation of antibiotics catalyzed by aminoglycoside nucleotidyltransferase 2''-I. | Q54383442 | ||
| Synthesis of 3'-deoxy-3'-fluorokanamycins A and B active against resistant bacteria. | Q54444543 | ||
| Expression of prokaryotic genes for hygromycin B and G418 resistance as dominant-selection markers in mouse L cells | Q54468305 | ||
| Structure-activity relationships of hygromycin A and its analogs: protein synthesis inhibition activity in a cell free system. | Q54564545 | ||
| 3',4'-dideoxy-kanamycin B active against kanamycin-resistant Escherichia coli and Pseudomonas aeruginosa | Q54668246 | ||
| Altered denA and anr gene expression in aminoglycoside adaptive resistance in Pseudomonas aeruginosa | Q57238285 | ||
| Mechanism of aminoglycoside 3'-phosphotransferase type IIIa: His188 is not a phosphate-accepting residue | Q59647666 | ||
| Synthesis of 4'-deoxy-4'-fluorokanamycin A and B | Q67573560 | ||
| Synthesis of 5-deoxy-5-fluoro and 5-deoxy-5,5-difluoro derivatives of kanamycin B and its analogs. Study on structure-toxicity relationships | Q67573571 | ||
| A synthesis of 3',4'-dideoxykanamycin B | Q67809653 | ||
| In vitro susceptibility to aminoglycoside antibiotics in blood and urine isolates consecutively collected in twenty-nine European laboratories. European Study Group on Antibiotic Resistance | Q68194936 | ||
| Aminoglycoside antibiotic treatment of human fibroblasts: intracellular accumulation, molecular changes and the loss of ribosomal accuracy | Q68988579 | ||
| Aminoglycoside antibiotics. II. Configurational and positional isomers of BB-K8 | Q69661389 | ||
| Letter: Syntheses of 1-n-(S)-4-amino-2-hydroxybutyryl)-kanamycin B and -3', 4'-dideoxykanamycin B active against kanamycin-resistant bacteria | Q69662851 | ||
| Determination of the rate-limiting segment of aminoglycoside nucleotidyltransferase 2''-I by pH and viscosity-dependent kinetics | Q69835168 | ||
| Interaction of gentamicin and spermine with bilayer membranes containing negatively charged phospholipids | Q70069613 | ||
| Chemical modification of amikacin at C-4'' with inversion of configuration | Q70111368 | ||
| Biphasic, concentration-dependent and rate-limited, concentration-independent bacterial killing by an aminoglycoside antibiotic | Q70502539 | ||
| Synthesis of low-toxicity, 5-deoxy-5-fluoro and 5-deoxy-5,5-difluoro derivatives of arbekacin and its analogs, and study of structure-toxicity relationships | Q70622908 | ||
| New 2''-amino derivatives of arbekacin, potent aminoglycoside antibiotics against methicillin-resistant Staphylococcus aureus | Q70671045 | ||
| The most frequently occurring aminoglycoside resistance mechanisms--combined results of surveys in eight regions of the world. The Aminoglycoside Resistance Study Groups | Q71059885 | ||
| Studies on a new aminoglycoside antibiotic, dactimicin. II. Isolation, structure and chemical degradation | Q71066927 | ||
| A prospective, randomized study of amikacin and gentamicin in serious infections with focus on efficacy, toxicity and duration of serum levels above the MIC | Q71104190 | ||
| Enzymatic 2'-N-acetylation of arbekacin and antibiotic activity of its product | Q71195666 | ||
| Selective elimination of fibroblasts from cultures of normal human melanocytes | Q71355336 | ||
| Synthesis and antimicrobial and toxicological studies of amino acid and peptide derivatives of kanamycin A and netilmicin | Q71514431 | ||
| Specificity of aminoglycoside binding to RNA constructs derived from the 16S rRNA decoding region and the HIV-RRE activator region | Q73040655 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 727-737 | |
| P577 | publication date | 1999-04-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Aminoglycosides: activity and resistance | |
| P478 | volume | 43 |
| Q39651757 | 30S ribosomal subunit assembly is a target for inhibition by aminoglycosides in Escherichia coli |
| Q42227266 | 6''-Thioether tobramycin analogues: towards selective targeting of bacterial membranes |
| Q42321888 | A bifunctional aminoglycoside acetyltransferase/phosphotransferase conferring tobramycin resistance provides an efficient selectable marker for plastid transformation. |
| Q42003848 | A chemoinformatics approach to the discovery of lead-like molecules from marine and microbial sources en route to antitumor and antibiotic drugs. |
| Q42685344 | A comparison of extended spectrum β-lactamase producing Escherichia coli from clinical, recreational water and wastewater samples associated in time and location. |
| Q35086954 | A degenerate PCR-based strategy as a means of identifying homologues of aminoglycoside and β-lactam resistance genes in the gut microbiota. |
| Q33723987 | A fluorescence-based screen for ribosome binding antibiotics |
| Q42137647 | A slow, tight-binding inhibitor of the zinc-dependent deacetylase LpxC of lipid A biosynthesis with antibiotic activity comparable to ciprofloxacin |
| Q64168419 | A stereoselective route towards highly functionalized 4,6-diaminocyclohexene derivatives |
| Q46359798 | Abundance and distribution of antibiotic resistance genes in a full-scale anaerobic-aerobic system alternately treating ribostamycin, spiramycin and paromomycin production wastewater. |
| Q35832535 | Activation of HIF-1α and LL-37 by commensal bacteria inhibits Candida albicans colonization |
| Q34933370 | Adaptation genomics of a small-colony variant in a Pseudomonas chlororaphis 30-84 biofilm. |
| Q55497000 | Advances in therapeutic use of a drug-stimulated translational readthrough of premature termination codons. |
| Q92958757 | Adverse outcome pathway for aminoglycoside ototoxicity in drug-resistant tuberculosis treatment |
| Q35214772 | Agents ameliorating or augmenting experimental gentamicin nephrotoxicity: some recent research |
| Q64274496 | Aminoglycoside Enhances the Delivery of Antisense Morpholino Oligonucleotides In Vitro and in mdx Mice |
| Q36418033 | Aminoglycoside Resistance in Clinical Isolates of Gram Negative Bacilli at the University Hospital of the West Indies, Jamaica: Comparison of Two Time Periods |
| Q36440293 | Aminoglycoside interactions with RNAs and nucleases. |
| Q92213559 | Aminoglycoside resistance mechanism inference algorithm: Implication for underlying resistance mechanisms to aminoglycosides |
| Q33831880 | Aminoglycoside resistance rates, phenotypes, and mechanisms of Gram-negative bacteria from infected patients in upper Egypt |
| Q34180913 | Aminoglycoside-free interventional antibiotic management in patients undergoing haemopoietic stem cell transplantation |
| Q38851189 | Aminoglycosides: An Overview |
| Q37610795 | Aminoglycosides: molecular insights on the recognition of RNA and aminoglycoside mimics. |
| Q33605648 | Aminoglycosides: nephrotoxicity |
| Q28138065 | Aminoglycosides: perspectives on mechanisms of action and resistance and strategies to counter resistance |
| Q34228285 | Analysis of the contribution of individual substituents in 4,6-aminoglycoside-ribosome interaction |
| Q52655525 | Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens? |
| Q33954740 | Antibiotic efflux pumps |
| Q94400760 | Antibiotic prophylaxis for people with cirrhosis and variceal bleeding |
| Q34130056 | Antibiotic resistance |
| Q36267597 | Antibiotic resistance markers in genetically modified plants: a risk to human health? |
| Q49790644 | Antibiotic resistance trends and mechanisms in the foodborne pathogen, Campylobacter |
| Q92616596 | Antibiotic resistant bacteria and commensal fungi are common and conserved in the mosquito microbiome |
| Q26744091 | Antibiotic strategies in the era of multidrug resistance |
| Q36421608 | Antibiotic use and abuse: a threat to mitochondria and chloroplasts with impact on research, health, and environment |
| Q38741995 | Antibiotics Resistance in Rhizobium: Type, Process, Mechanism and Benefit for Agriculture. |
| Q34156349 | Antibiotics and bacterial resistance in the 21st century |
| Q57103893 | Antifungal amphiphilic kanamycins: new life for an old drug |
| Q38622878 | Antimicrobial susceptibility patterns of clinical isolates of Pseudomonas aeruginosa isolated from patients of respiratory tract infections in a Tertiary Care Hospital, Peshawar |
| Q33978958 | Apoptosis in renal proximal tubules of rats treated with low doses of aminoglycosides |
| Q38898933 | Apoptosis induced by aminoglycosides in LLC-PK1 Cells: comparative study of neomycin, gentamicin, amikacin, and isepamicin using electroporation |
| Q40675239 | Arbekacin activity against contemporary clinical bacteria isolated from patients hospitalized with pneumonia |
| Q37203715 | Association between the Presence of Aminoglycoside-Modifying Enzymes and In Vitro Activity of Gentamicin, Tobramycin, Amikacin, and Plazomicin against Klebsiella pneumoniae Carbapenemase- and Extended-Spectrum-β-Lactamase-Producing Enterobacter Spec |
| Q51037201 | Bacterial adaptation to sublethal antibiotic gradients can change the ecological properties of multitrophic microbial communities. |
| Q38757741 | Bacterial contamination in intensive care unit at Al-Imam Al-Hussein Hospital in Thi-qar province in Iraq |
| Q55339999 | Bacteriological profile and antimicrobial susceptibility patterns of urine culture isolates from patients in Ndjamena, Chad. |
| Q28477274 | Bacteriophage-resistant mutants in Yersinia pestis: identification of phage receptors and attenuation for mice |
| Q34510638 | Binding of neomycin-class aminoglycoside antibiotics to mutant ribosomes with alterations in the A site of 16S rRNA. |
| Q37650423 | Biofilm development and enhanced stress resistance of a model, mixed-species community biofilm |
| Q47141790 | Biophysical and enzymatic properties of aminoglycoside adenylyltransferase AadA6 from Pseudomonas aeruginosa. |
| Q93074400 | Chemical-Chemical Combinations Map Uncharted Interactions in Escherichia coli under Nutrient Stress |
| Q64267770 | Ciprofloxacin, amoxicillin, and aminoglycosides stimulate genetic and phenotypic changes in uropathogenic Escherichia coli strains |
| Q34489685 | Coagulase-negative staphylococcal skin carriage among neonatal intensive care unit personnel: from population to infection |
| Q67227791 | Combating bacterial resistance by combination of antibiotics with antimicrobial peptides |
| Q39652231 | Combination of quinupristin-dalfopristin and gentamicin against methicillin-resistant Staphylococcus aureus: experimental rabbit endocarditis study |
| Q28550306 | Comparative Fitness of a Parent Leishmania donovani Clinical Isolate and Its Experimentally Derived Paromomycin-Resistant Strain |
| Q43501875 | Comparative antibacterial activity of a novel semisynthetic antibiotic: etimicin sulphate and other aminoglycosides |
| Q37121962 | Complementation of Arginine Auxotrophy for Genetic Transformation of Coxiella burnetii by Use of a Defined Axenic Medium |
| Q53802828 | Conditional probability analysis of multidrug resistance in Gram-negative bacilli isolated from tertiary medical institutions in South Korea during 1999-2009. |
| Q39925826 | Conformational Response of 30S-bound IF3 to A-Site Binders Streptomycin and Kanamycin. |
| Q27640504 | Crystal structure of geneticin bound to a bacterial 16S ribosomal RNA A site oligonucleotide |
| Q27647572 | Crystal structure of the bacterial ribosomal decoding site complexed with a synthetic doubly functionalized paromomycin derivative: a new specific binding mode to an a-minor motif enhances in vitro antibacterial activity |
| Q42001317 | Crystallization and preliminary crystallographic analysis of hygromycin B phosphotransferase from Escherichia coli |
| Q55491712 | De novo assembly and comparative transcriptome analysis of Monilinia fructicola, Monilinia laxa and Monilinia fructigena, the causal agents of brown rot on stone fruits. |
| Q44198500 | Deletion of gene encoding methyltransferase (gidB) confers high-level antimicrobial resistance in Salmonella. |
| Q50079038 | Destination of aminoglycoside antibiotics in the 'post-antibiotic era'. |
| Q57215473 | Distribution of conjugative-plasmid-mediated 16S rRNA methylase genes among amikacin-resistant Enterobacteriaceae isolates collected in 1995 to 1998 and 2001 to 2006 at a university hospital in South Korea and identification of conjugative plasmids m |
| Q54053475 | Do antibiotics maintain antibiotic resistance? |
| Q36871054 | ESBL genotypes in fluoroquinolone-resistant and fluoroquinolone-susceptible ESBL-producing Escherichia coli urinary isolates in Manitoba |
| Q38653386 | Effect of solvent and protein dynamics in ligand recognition and inhibition of aminoglycoside adenyltransferase 2″-Ia |
| Q43693817 | Effect of the exposure to gentamicin and diltiazem on the permeability of model membranes. |
| Q42948726 | Effects of glutathione and ascorbic acid on streptomycin sensitivity of Escherichia coli |
| Q42731688 | Efficacy of neutral and negatively charged liposome-loaded gentamicin on planktonic bacteria and biofilm communities. |
| Q37182594 | Efficient Eradication of Mature Pseudomonas aeruginosa Biofilm via Controlled Delivery of Nitric Oxide Combined with Antimicrobial Peptide and Antibiotics. |
| Q89529481 | Emerging Treatment Options for Infections by Multidrug-Resistant Gram-Positive Microorganisms |
| Q61454199 | Establishment of a Gentamicin Cochlear Poisoning Model in Guinea Pigs and Cochlear Nerve Endings Recognition of Ultrasound Signals |
| Q28552193 | Evaluation of the Interaction between the Poincianella pyramidalis (Tul.) LP Queiroz Extract and Antimicrobials Using Biological and Analytical Models |
| Q44645277 | Evolution of aminoglycoside resistance phenotypes of four Gram-negative bacteria: an 8-year survey in a University Hospital in Greece. |
| Q46921246 | Experimental selection of paromomycin and miltefosine resistance in intracellular amastigotes of Leishmania donovani and L. infantum |
| Q57295334 | Fermentation: A Boon for Production of Bioactive Compounds by Processing of Food Industries Wastes (By-Products) |
| Q92756013 | Formulation of Antimicrobial Tobramycin Loaded PLGA Nanoparticles via Complexation with AOT |
| Q36439089 | Gallium Potentiates the Antibacterial Effect of Gentamicin against Francisella tularensis |
| Q30882914 | Genome-scale identification method applied to find cryptic aminoglycoside resistance genes in Pseudomonas aeruginosa |
| Q37019291 | Genomics of high molecular weight plasmids isolated from an on-farm biopurification system |
| Q91769245 | Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial |
| Q36050344 | High Levels of Antibiotic Resistance Genes and Their Correlations with Bacterial Community and Mobile Genetic Elements in Pharmaceutical Wastewater Treatment Bioreactors |
| Q33876486 | Homozygous triplicate mutations in three 16S rRNA genes responsible for high-level aminoglycoside resistance in Nocardia farcinica clinical isolates from a Canada-wide bovine mastitis epizootic. |
| Q90265385 | Hypoionic Shock Facilitates Aminoglycoside Killing of Both Nutrient Shift- and Starvation-Induced Bacterial Persister Cells by Rapidly Enhancing Aminoglycoside Uptake |
| Q53777899 | Identification of Genes Coding Aminoglycoside Modifying Enzymes in E. coli of UTI Patients in India. |
| Q47102404 | In Vitro Activity of Neomycin, Streptomycin, Paromomycin and Apramycin against Carbapenem-Resistant Enterobacteriaceae Clinical Strains. |
| Q88984613 | In Vitro Activity of Plazomicin against Gram-Negative and Gram-Positive Isolates Collected from U.S. Hospitals and Comparative Activities of Aminoglycosides against Carbapenem-Resistant Enterobacteriaceae and Isolates Carrying Carbapenemase Genes |
| Q35064275 | In silico assigned resistance genes confer Bifidobacterium with partial resistance to aminoglycosides but not to β-lactams |
| Q41976880 | In vitro activity of the aminoglycoside antibiotic arbekacin against Acinetobacter baumannii-calcoaceticus isolated from war-wounded patients at Walter Reed Army Medical Center. |
| Q36949450 | In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme. |
| Q41972475 | In vitro antimicrobial susceptibility to isepamicin of 6,296 Enterobacteriaceae clinical isolates collected at a tertiary care university hospital in Greece. |
| Q37392858 | In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic |
| Q79256209 | InBr3‐Catalyzed Cyclization of Glycals with Aryl Amines |
| Q92764911 | Integron-Derived Aminoglycoside-Sensing Riboswitches Control Aminoglycoside Acetyltransferase Resistance Gene Expression |
| Q30454411 | Intracellular mechanisms of aminoglycoside-induced cytotoxicity. |
| Q89791799 | Investigation of antibiotic resistance determinants and virulence factors of uropathogenic Escherichia coli |
| Q34597573 | KPC-producing Klebsiella pneumoniae strains that harbor AAC(6')-Ib exhibit intermediate resistance to amikacin |
| Q46482071 | Kanamycin A-derived cationic lipids as vectors for gene transfection |
| Q36575916 | Mechanisms of Resistance to Aminoglycoside Antibiotics: Overview and Perspectives |
| Q39478577 | Mechanisms of streptomycin resistance: selection of mutations in the 16S rRNA gene conferring resistance |
| Q37056193 | Mild and convenient N-formylation protocol in water-containing solvents |
| Q38827899 | Modeling intraocular bacterial infections |
| Q33568939 | Monoclonal antibody-based ELISA and colloidal gold-based immunochromatographic assay for streptomycin residue detection in milk and swine urine |
| Q37662838 | Morin hydrate promotes inner ear neural stem cell survival and differentiation and protects cochlea against neuronal hearing loss |
| Q33768781 | Mutant APH(2'')-IIa enzymes with increased activity against amikacin and isepamicin |
| Q61806023 | Mycobacterial Aminoglycoside Acetyltransferases: A Little of Drug Resistance, and a Lot of Other Roles |
| Q35752292 | NaHS Protects Cochlear Hair Cells from Gentamicin-Induced Ototoxicity by Inhibiting the Mitochondrial Apoptosis Pathway |
| Q48281604 | Natural Products as Platforms To Overcome Antibiotic Resistance |
| Q37599657 | Nature as a source of inspiration for cationic lipid synthesis. |
| Q58376391 | Niche partitioning of a pathogenic microbiome driven by chemical gradients |
| Q92071424 | Nitric oxide-releasing hyperbranched polyaminoglycosides for antibacterial therapy |
| Q39746485 | Novel 3-N-aminoglycoside acetyltransferase gene, aac(3)-Ic, from a Pseudomonas aeruginosa integron |
| Q37610278 | Novel thermostable antibiotic resistance enzymes from the Atlantis II Deep Red Sea brine pool. |
| Q34543034 | Occurrence and spread of antibiotic resistances in Enterococcus faecium |
| Q42861098 | On the interaction of neomycin with the slow vacuolar channel of Arabidopsis thaliana |
| Q41963116 | Optimal aminoglycoside therapy following the sepsis: how much is too much? |
| Q51367951 | Overexpression of an Arabidopsis thaliana ABC transporter confers kanamycin resistance to transgenic plants. |
| Q90101221 | Perioperative Antibiotics in Clean-Contaminated Head and Neck Surgery: A Systematic Review and Meta-Analysis |
| Q28478449 | Phenotypic and genome-wide analysis of an antibiotic-resistant small colony variant (SCV) of Pseudomonas aeruginosa |
| Q38283201 | Phylogenetic sequence variations in bacterial rRNA affect species-specific susceptibility to drugs targeting protein synthesis |
| Q41977158 | Phytochemical prospection and modulation of antibiotic activity in vitro by Lippia origanoides H.B.K. in methicillin resistant Staphylococcus aureus. |
| Q42111823 | Plasmid-mediated 16S rRNA methylases in aminoglycoside-resistant Enterobacteriaceae isolates in Shanghai, China |
| Q99580010 | Plazomicin: a new aminoglycoside in the fight against antimicrobial resistance |
| Q50351287 | Prevalence and Genetic Basis of Antimicrobial Resistance in Non-aureus Staphylococci Isolated from Canadian Dairy Herds |
| Q41823699 | Prior antibacterial peptide-mediated inhibition of protein folding in bacteria mutes resistance enzymes |
| Q28492782 | Proteomic, microarray, and signature-tagged mutagenesis analyses of anaerobic Pseudomonas aeruginosa at pH 6.5, likely representing chronic, late-stage cystic fibrosis airway conditions |
| Q41193471 | QSAR-assisted virtual screening of lead-like molecules from marine and microbial natural sources for antitumor and antibiotic drug discovery. |
| Q35326720 | RNA-seq analysis of the effect of kanamycin and the ABC transporter AtWBC19 on Arabidopsis thaliana seedlings reveals changes in metal content |
| Q38819114 | Raf-kinase inhibitor GW5074 shows antibacterial activity against methicillin-resistant Staphylococcus aureus and potentiates the activity of gentamicin |
| Q34721661 | Reverse engineering antibiotic sensitivity in a multidrug-resistant Pseudomonas aeruginosa isolate |
| Q37278886 | Riboswitch control of induction of aminoglycoside resistance acetyl and adenyl-transferases |
| Q39640541 | Role of tfxE, but not tfxG, in trifolitoxin resistance |
| Q61755414 | Screening of Preselected Libraries Targeting Mycobacterium abscessus for Drug Discovery |
| Q34283886 | Selectively guanidinylated aminoglycosides as antibiotics |
| Q36867716 | Small Molecule Targeting of a MicroRNA Associated with Hepatocellular Carcinoma |
| Q33968990 | Spontaneous and evolutionary changes in the antibiotic resistance of Burkholderia cenocepacia observed by global gene expression analysis |
| Q26859978 | Strategies to overcome the action of aminoglycoside-modifying enzymes for treating resistant bacterial infections |
| Q91254622 | Stressor interaction networks suggest antibiotic resistance co-opted from stress responses to temperature |
| Q27659071 | Structure of the Antibiotic Resistance Factor Spectinomycin Phosphotransferase from Legionella pneumophila |
| Q36647895 | Structure-based organic synthesis of drug prototypes: a personal odyssey |
| Q41190361 | Study of aminoglycoside resistance genes in enterococcus and salmonella strains isolated from ilam and milad hospitals, iran |
| Q28602834 | Study of the Aminoglycoside Subsistence Phenotype of Bacteria Residing in the Gut of Humans and Zoo Animals |
| Q27638972 | Substrate promiscuity of an aminoglycoside antibiotic resistance enzyme via target mimicry |
| Q53770759 | Substrate specificity of radical S-adenosyl-l-methionine dehydratase AprD4 and its partner reductase AprD3 in the C3'-deoxygenation of aminoglycoside antibiotics. |
| Q37147220 | Surprising alteration of antibacterial activity of 5"-modified neomycin against resistant bacteria. |
| Q42104159 | Synergistic effect of Thymbra spicata L. extracts with antibiotics against multidrug- resistant Staphylococcus aureus and Klebsiella pneumoniae strains |
| Q37216483 | Synthesis and antibacterial activity of pyranmycin derivatives with N-1 and O-6 modifications |
| Q64903384 | Teaching an Old Class New Tricks: A Novel Semi-Synthetic Aminoglycoside, Plazomicin. |
| Q30391524 | Temperature-Dependent Gentamicin Resistance of Francisella tularensis is Mediated by Uptake Modulation |
| Q39015101 | The Influence of the Toxin/Antitoxin mazEF on Growth and Survival of Listeria monocytogenes under Stress |
| Q26786956 | The Three Bacterial Lines of Defense against Antimicrobial Agents |
| Q33968209 | The biology and synthesis of α-hydroxytropolones |
| Q45934534 | The effect of PAMAM dendrimers on the antibacterial activity of antibiotics with different water solubility. |
| Q41331869 | The kinetic mechanism of AAC3-IV aminoglycoside acetyltransferase from Escherichia coli |
| Q36752156 | The rise of the Enterococcus: beyond vancomycin resistance |
| Q37409465 | Therapeutic drug monitoring of aminoglycosides in neonates |
| Q43103386 | Transgenic hybrid aspen overexpressing the Atwbc19 gene encoding an ATP-binding cassette transporter confers resistance to four aminoglycoside antibiotics. |
| Q47101582 | Ubiquitous Nature of Fluoroquinolones: The Oscillation between Antibacterial and Anticancer Activities. |
| Q79291069 | Use of Parenteral Colistin for the Treatment of Serious Infection Due to Antimicrobial-Resistant Pseudomonas aeruginosa |
| Q35102420 | Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniae |
| Q50484768 | [Aminoglycosides]. |
| Q42184041 | armA and aminoglycoside resistance in Escherichia coli |
| Q36505262 | novel 6'-n-aminoglycoside acetyltransferase AAC(6')-Iaj from a clinical isolate of Pseudomonas aeruginosa |
| Q42110968 | walK and clpP mutations confer reduced vancomycin susceptibility in Staphylococcus aureus. |
Search more.